London – 7th June 2012. Infectious disease in-vitro diagnostics (IVD) refers to the testing of patient specimens ordered by a physician for diagnosis of an infectious disease on an emergency basis. This web conference will provide an overview of key infectious diseases, namely malaria, dengue, tuberculosis, sexually transmitted infections (STIs), hepatitis C, influenza and pertussis. The presentation will also cover industry trends, competitive strategies and diagnostic technologies for infectious diseases in the Asia Pacific (APAC) market.
Frost & Sullivan will host a complimentary web conference entitled “ Discover Asia Pacific Infectious Disease Diagnostics Market Trends”, which will take place on Thursday 14th June at 6.00 pm BST. Consultant Poomina Srinivasan has completed extensive analysis on the APAC Infectious Disease Diagnostics Market. The research expert will lead a short teleconference about new finding that affect the market, followed by a live question-and-answer session.
Highlights of the web conference will include determining if the APAC infectious IVD market is growing, how long it will continue to grow and at what rate, as well as an overview of the key infectious disease in major countries of APAC, identifying fundamental drivers and restraints as well as key strategies, for the infectious disease testing industry and learning about the life cycle of IVD technologies in APAC.
To participate in this complimentary web conference, please email Janique Morvan, Corporate Communications at email@example.com, with your full contact details. Upon receipt of the above-mentioned information, a registration link will be emailed to you.
This web conference will benefit global IVD test manufacturers, medical device manufacturers, and clinical laboratory suppliers/distributors by discussing industry challenges and forward projections for the APAC infectious disease IVD market.
“The need for infectious disease testing on an emergency basis, combined with demand for quality healthcare, the push for improving the economy and the expanding aging demographic are significant drivers for infectious disease diagnostic testing,” said Frost & Sullivan Healthcare Consultant Poomina Srinivasan. “However, the market is hampered by regulations on importing IVD devices as well s reimbursement for clinical tests using sophisticated technologies, such as molecular diagnostics. As APAC is positioned as the preferred destination for medical tourism, the web conference will cover the need for adapting new strategies in this competitive environment.”
To receive a link of the recorded web conference and/or further information on this research, please email Janique Morvan at firstname.lastname@example.org with your full contact details.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Corporate Communications – Europe
P: +33 (0)1 42 81 20 37
M: +33 (0)6 79 22 41 42